UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000031335
Receipt No. R000035748
Official scientific title of the study A randomized control trial of herbal medicine for cancer patients that examined influence of IL-6 and cachexy.
Date of disclosure of the study information 2018/02/16
Last modified on 2018/02/16 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A randomized control trial of herbal medicine for cancer patients that examined influence of IL-6 and cachexy.
Title of the study (Brief title) Influence of the herbal medicine
Region
Japan

Condition
Condition colorectal cancer, pancreatic cancer
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Relative dose intensity of first line chemothrapy
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes MTD, RD,IL-6
Key secondary outcomes QOL Nutritional assessment

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Hochuekkitou, gosyajinnkigan, keisibukuryogan

Interventions/Control_2 control
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
85 years-old >=
Gender Male and Female
Key inclusion criteria "(1) Histological proven adenocarcinoma
(2) possible oral intake
(3) unresectable corolectal and pancreatic cancer
(4) KRAS mutation untested or negative or positive
(5) PS 0-1
(6) Adequate organ function
(7) Written informed consent from patients
(8) Capcitabine + Oxalipltain + Bevacizumab regimen in patients with colorectal cancer
(9) Gemcitabine + Nab-paclitaxel in patients with pancreatic cancer
(10) Best surpotive care in study2"
Key exclusion criteria "(1) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy.
(2) Past history of severe hypersensitivity to drugs
(3) Body temperature of over 38 degrees Celsius or active infection
(4) serious bone marrow suppression, a renal damage or a liver damage
(5) Severe complications
(6) Pregnant women, women with the possibility of the pregnancy, or men who want their partners to become pregnant
(7) Psychological disorder
(8) Patients judged inappropriate for the study by the physicians
"
Target sample size 60

Research contact person
Name of lead principal investigator Masahiro Gotou
Organization Osaka Medical College Hospital
Division name Chemotherapy Center
Address 2-7 Daigaku-machi, Takatsuki City, Osaka, Japan
TEL 072-683-1221
Email in2030@osaka-med.ac.jp

Public contact
Name of contact person Toshifumi Yamaguchi
Organization Osaka Medical College Hospital
Division name Chemotherapy Center
Address 2-7 Daigaku-machi, Takatsuki City, Osaka, Japan
TEL 072-683-1221
Homepage URL
Email ctc008@osaka-med.ac.jp

Sponsor
Institute Osaka Medical College Hospital
Institute
Department

Funding Source
Organization Grants-in-Aid for Scientific Research
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 16 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 12 Month 30 Day
Anticipated trial start date
2017 Year 12 Month 30 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 02 Month 16 Day
Last modified on
2018 Year 02 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035748